BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 11369804)

  • 21. The significance of apolipoprotein E structure to the metabolism of plasma triglyceride-rich lipoproteins.
    Dergunov AD; Rosseneu M
    Biol Chem Hoppe Seyler; 1994 Aug; 375(8):485-95. PubMed ID: 7811390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heparan sulfate proteoglycans mediate internalization and degradation of beta-VLDL and promote cholesterol accumulation by pigeon macrophages.
    Seo T; St Clair RW
    J Lipid Res; 1997 Apr; 38(4):765-79. PubMed ID: 9144091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apolipoprotein E is resistant to intracellular degradation in vitro and in vivo. Evidence for retroendocytosis.
    Rensen PC; Jong MC; van Vark LC; van der Boom H; Hendriks WL; van Berkel TJ; Biessen EA; Havekes LM
    J Biol Chem; 2000 Mar; 275(12):8564-71. PubMed ID: 10722695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Syndecan-1 mediates internalization of apoE-VLDL through a low density lipoprotein receptor-related protein (LRP)-independent, non-clathrin-mediated pathway.
    Wilsie LC; Gonzales AM; Orlando RA
    Lipids Health Dis; 2006 Aug; 5():23. PubMed ID: 16945147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The very low- and intermediate-density lipoprotein fraction isolated from apolipoprotein E-knockout mice transforms macrophages to foam cells through an apolipoprotein E-independent pathway.
    Hakamata H; Sakaguchi H; Zhang C; Sakashita N; Suzuki H; Miyazaki A; Takeya M; Takahashi K; Kitamura N; Horiuchi S
    Biochemistry; 1998 Sep; 37(39):13720-7. PubMed ID: 9753460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
    Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ
    Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Secretion-capture role for apolipoprotein E in remnant lipoprotein metabolism involving cell surface heparan sulfate proteoglycans.
    Ji ZS; Fazio S; Lee YL; Mahley RW
    J Biol Chem; 1994 Jan; 269(4):2764-72. PubMed ID: 8300609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sustained-delivery of an apolipoprotein E-peptidomimetic using multivesicular liposomes lowers serum cholesterol levels.
    Ramprasad MP; Anantharamaiah GM; Garber DW; Katre NV
    J Control Release; 2002 Feb; 79(1-3):207-18. PubMed ID: 11853932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Uptake of hypertriglyceridemic very low density lipoproteins and their remnants by HepG2 cells: the role of lipoprotein lipase, hepatic triglyceride lipase, and cell surface proteoglycans.
    Huff MW; Miller DB; Wolfe BM; Connelly PW; Sawyez CG
    J Lipid Res; 1997 Jul; 38(7):1318-33. PubMed ID: 9254059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of anti-endotoxin activity of apoE and apoA mimetic derivatives of a model amphipathic peptide 18A.
    Sharifov OF; Nayyar G; Ternovoy VV; Palgunachari MN; Garber DW; Anantharamaiah G; Gupta H
    Innate Immun; 2014 Nov; 20(8):867-80. PubMed ID: 24323453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipolysis is a prerequisite for lipid accumulation in HepG2 cells induced by large hypertriglyceridemic very low density lipoproteins.
    Evans AJ; Sawyez CG; Wolfe BM; Huff MW
    J Biol Chem; 1992 May; 267(15):10743-51. PubMed ID: 1587849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Uptake of type IV hypertriglyceridemic VLDL by cultured macrophages is enhanced by interferon-gamma.
    Whitman SC; Argmann CA; Sawyez CG; Miller DB; Hegele RA; Huff MW
    J Lipid Res; 1999 Jun; 40(6):1017-28. PubMed ID: 10357833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential cellular accumulation/retention of apolipoprotein E mediated by cell surface heparan sulfate proteoglycans. Apolipoproteins E3 and E2 greater than e4.
    Ji ZS; Pitas RE; Mahley RW
    J Biol Chem; 1998 May; 273(22):13452-60. PubMed ID: 9593678
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure-function relationship of lipoprotein lipase-mediated enhancement of very low density lipoprotein binding and catabolism by the low density lipoprotein receptor. Functional importance of a properly folded surface loop covering the catalytic center.
    Salinelli S; Lo JY; Mims MP; Zsigmond E; Smith LC; Chan L
    J Biol Chem; 1996 Sep; 271(36):21906-13. PubMed ID: 8702993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Uptake by J774 macrophages of very-low-density lipoproteins isolated from apoE-deficient mice is mediated by a distinct receptor and stimulated by lipoprotein lipase.
    Hendriks WL; van der Sman-de Beer F; van Vlijmen BJ; van Vark LC; Hofker MH; Havekes LM
    Arterioscler Thromb Vasc Biol; 1997 Mar; 17(3):498-504. PubMed ID: 9102168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heparan sulfate proteoglycans participate in hepatic lipaseand apolipoprotein E-mediated binding and uptake of plasma lipoproteins, including high density lipoproteins.
    Ji ZS; Dichek HL; Miranda RD; Mahley RW
    J Biol Chem; 1997 Dec; 272(50):31285-92. PubMed ID: 9395455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhancement of the binding of triglyceride-rich lipoproteins to the very low density lipoprotein receptor by apolipoprotein E and lipoprotein lipase.
    Takahashi S; Suzuki J; Kohno M; Oida K; Tamai T; Miyabo S; Yamamoto T; Nakai T
    J Biol Chem; 1995 Jun; 270(26):15747-54. PubMed ID: 7797576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nascent very-low-density lipoprotein triacylglycerol hydrolysis by lipoprotein lipase is inhibited by apolipoprotein E in a dose-dependent manner.
    Jong MC; Dahlmans VE; Hofker MH; Havekes LM
    Biochem J; 1997 Dec; 328 ( Pt 3)(Pt 3):745-50. PubMed ID: 9396715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral administration of L-mR18L, a single domain cationic amphipathic helical peptide, inhibits lesion formation in ApoE null mice.
    Handattu SP; Datta G; Epand RM; Epand RF; Palgunachari MN; Mishra VK; Monroe CE; Keenum TD; Chaddha M; Anantharamaiah GM; Garber DW
    J Lipid Res; 2010 Dec; 51(12):3491-9. PubMed ID: 20841495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence that cholesteryl ester and triglyceride accumulation in J774 macrophages induced by very low density lipoprotein subfractions occurs by different mechanisms.
    Evans AJ; Sawyez CG; Wolfe BM; Connelly PW; Maguire GF; Huff MW
    J Lipid Res; 1993 May; 34(5):703-17. PubMed ID: 8509711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.